SALIX® (furosemide injection) – Canine & Feline
Salix is a diuretic-saluretic used for edema associated with cardiac insufficiency and acute non-inflammatory tissue edema in dogs and cats.
LEARN MORELT-IVAX®
For the vaccination of healthy chickens 4-weeks or older against infectious fowl laryngotracheitis.
LEARN MOREINNOVAX®-ND-ILT
For vaccination of healthy 18-day old chicken embryos or 1-day old chickens against Marek’s disease, ND and infectious laryngotracheitis.
LEARN MOREINNOVAX®-ND-IBD
For vaccination of healthy 18-day old chicken embryos or 1-day old chickens for prevention of Marek’s disease, ND, IBD (Standard and Variant).
LEARN MOREINNOVAX-ND
For vaccination of healthy 18-day old chicken embryos or 1-day old chickens for the prevention of Marek’s disease and Newcastle disease.
LEARN MORENobivac® 3-Rabies CA
NOBIVAC 3-RABIES CA vaccine meets state guidelines and is approved for sale in California to protect pets against rabies.
LEARN MORENOBIVAC® 3-Rabies
NOBIVAC 3-RABIES vaccine provides protection against rabies in dogs and cats for at least three years, and ferrets for one year.
LEARN MOREINNOVAX®-ILT-SB
For vaccination of healthy 18-day old chicken embryos or 1-day old chickens for the prevention of Marek’s disease and Infectious Laryngotracheitis.
LEARN MORENOBIVAC® 1-Rabies
Show effective against rabies for one year protection in healthy dogs, cats and ferrets.
LEARN MOREINNOVAX®-ILT-IBD
For vaccination of healthy 18-day old chicken embryos or 1-day old chickens for the prevention of Marek’s disease, ILT and IBD disease.
LEARN MOREINNOVAX®-ILT
For vaccination of healthy 18-day old chicken embryos or 1-day old chickens for the prevention of Marek’s disease and Infectious Laryngotracheitis.
LEARN MOREGilvetmab
Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MORE
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global